Alkermes
ALKS
#2133
Rank
A$13.30 B
Marketcap
A$79.81
Share price
4.26%
Change (1 day)
82.23%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): A$0.36 Billion

According to Alkermes's latest financial reports the company's current earnings are A$1.56 Billion. In 2025 the company made an earning of A$0.44 Billion a decrease over its 2024 earnings that were of A$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.36 B-17.98%
2025 A$0.44 B-34.87%
2024 A$0.67 B-17.97%
2023 A$0.82 B-468.52%
2022 -A$0.23 Billion449.24%
2021 -A$40.7 Million-68.04%
2020 -A$0.13 Billion-52.1%
2019 -A$0.27 Billion64.49%
2018 -A$0.17 Billion-15.04%
2017 -A$0.2 Billion-34.2%
2016 -A$0.29 Billion-5.34%
2015 -A$0.31 Billion35084.97%
2014 -A$0.87 Million
2012 A$10.75 M-117.81%
2011 -A$60.4 Million-12.69%
2010 -A$69.18 Million94.3%
2009 -A$35.61 Million-117.7%
2008 A$0.20 B622.63%
2007 A$27.83 M
2004 -A$0.12 Billion-14.48%
2003 -A$0.13 Billion11.88%
2002 -A$0.12 Billion39.65%
2001 -A$82.4 Million5.73%
2000 -A$77.93 Million-28.91%
1999 -A$0.11 Billion237.28%
1998 -A$32.5 Million100.05%
1997 -A$16.25 Million-37.93%
1996 -A$26.17 Million82.72%
1995 -A$14.33 Million-26.79%
1994 -A$19.57 Million-72.78%
1993 -A$71.88 Million208.07%
1992 -A$23.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.64 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.87 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.34 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.09 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$13.90 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$21.24 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-A$0.31 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.4 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.29 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel